Marvell Technology vs. Broadcom: Which Custom AI Chip Stock Has More Upside?

Marvell reported fiscal Q4 revenue of $2.22B (+22% YoY) and adjusted EPS $0.80 (+33% YoY), raised fiscal 2027 guidance to $11B and is targeting $15B for fiscal 2028 after custom processor revenue doubled and plans to produce >20 chip types. Broadcom posted fiscal Q1 revenue up 29% YoY with adjusted EPS $2.05, AI revenue of $8.4B (+106% YoY) and is guiding AI revenue to $10.7B next quarter (+143% YoY), targeting $100B in AI revenue in fiscal 2027 and an expected ~60% custom-AI-chip share in 2027. Investment implication: both stocks are well positioned for ASIC-driven AI inference demand, but Marvell offers a cheaper valuation for value-seeking investors while Broadcom commands share and justifies a premium for best-of-breed exposure.

Analysis

The transition from general-purpose GPUs to task-optimized ASICs shifts the competitive battleground from pure silicon performance to systems-level execution: customers now prize integrated delivery (chip + firmware + test + packaging) and predictable supply cadence as much as per-watt efficiency. That elevates firms with entrenched procurement control, multi-year supply contracts, and advanced substrate/packaging capability — a bottleneck that can create 6–18 month windows of outsized margin capture for incumbents while starving fast-followers who lack qualified material suppliers. Expect a cascade: optical transceiver, high-speed SERDES, and advanced substrate vendors see demand spikes ahead of system revenue, and hyperscalers’ procurement cadence will serially re-price winners well before public earnings fully reflect it.

Key risks are timing, customer concentration, and ASP deflation. Ramps that look clean on roadmap can be set back by packaging yield, firmware maturity, or a single hyperscaler pivot to internal designs; any one of those reversals can cut near-term revenue by multiples of a quarter’s forecast. Regulatory/anticompetitive scrutiny is a non-linear tail risk — a de facto single-source supplier for inference ASICs creates political and contract-risk that could manifest over 12–36 months and materially compress multiples.

From a horizon perspective, optionality is front-loaded: 3–9 month catalysts include customer production qualifications and announced capacity commitments; 12–24 months is where re-rating or consolidation happens. The market appears to be pricing a premium for scale and supply certainty; value-traders can capture asymmetric upside if they identify suppliers with qualified ramps but lower multiples, while growth-focused players should pay for supply-certain incumbency but hedge regulatory and ASP risks.

Key Decisions for Investors

• Long MRVL (12–18 months): Initiate a core long position sized 2–3% NAV to capture re-rating if multi-design ramps validate. Target +45–60% upside to a re-rated multiple; hard stop at -18% to protect against single-customer derates. Rationale: lower multiple already embeds some execution risk — upside is re-rate once 2–3 customer programs hit sustained shipments.
• Long AVGO via 18–24 month call-spread (debit) to cap cost: Buy an ATM-to-lean-OOTM call spread (~0.25–0.40 net delta) sized 1–2% NAV equivalent. Reward: asymmetric upside if supply-chain control and share gains continue; Risk: capped loss limited to premium paid, protects against multiple compression if growth disappoints. Use proceeds to sell near-term calls to finance premium where appropriate.
• Pair trade — Long MRVL / Short AVGO (6–12 months): Size 1:1 dollar exposure to express value vs incumbent premium. Target spread contraction where MRVL outperforms by 20–30%; if AVGO faces regulatory headlines or ASP erosion, the pair amplifies alpha. Implement stop-loss if either leg moves >25% adverse within 30 days to limit dispersion risk.
• Hedge/insurance — Buy short-dated puts on leading hyperscaler customers (eg GOOGL/META) or a small NVDA put position (3–9 months): Allocate 0.5–1% NAV as tail hedges against abrupt hyperscaler buying pauses or a sudden GPU-to-ASIC shift. These protect portfolio exposure to demand shocks and asymmetric downside from a single-customer procurement change.